1. Pál S, Solymár M, Réger B, Alizadeh H, Vereczkei A, Kiss T, et al. Specific Trends in Blood Utilization During the COVID-19 Pandemic: A Retrospective Analysis of a Hungarian Clinical Centre. J Clin Med. 2025; 14(22): 7943. [
DOI:10.3390/jcm14227943] [
PMID] [
PMCID]
2. Ranjbar Kermani FR, Amini Kafi-Abad S. Trend of blood donation including coronavirus pandemic: A nationwide cross-sectional study during 2017-2022 in Iran. Transfus Clin Biol. 2025; 32(3): 272-9. [
DOI:10.1016/j.tracli.2025.04.007] [
PMID]
3. Das SS, Biswas RN. Alterations in blood component utilization in a tertiary care hospital in eastern India in the COVID-19 pandemic. Asian J Transfus Sci. 2022; 16(1): 36-40. [
DOI:10.4103/ajts.AJTS_122_20] [
PMID] [
PMCID]
4. Rafieemehr H, Majidi L, Jahangiri A. The ratio of cross-matched blood to transfusion in trauma patients receiving blood in the emergency department of Besat hospital in Hamadan in 2020. J Iran Blood Transfus. 2021;18(3):196-204.
5. Karbasian F, Zafari A, Goudarzipour K, Mesdaghi M, Shariatzadeh S, Eshghi P. Evaluation of Changes in Blood Products Transfusion Indices Following three years of Implementation of Iranian Blood Transfusion Organization Standards. IJBC 2019; 11(4): 133-8.
6. Haghpanah S, Miladi S, Kasraian L, Zamani A, Gholami M. Blood Transfusion Practice in Operating Rooms in Nemazee Hospital in Southern Iran. Arch Iran Med. 2021; 24(2):107-12. [
DOI:10.34172/aim.2021.16] [
PMID]
7. Kour S, Yasmeen I, Jan A, Singh B. Analysis of cross matching to transfusion ratio of blood components in blood bank SKIMS, Soura: a prospective one year study. Int J Res Med Sci. 2019; 7(12): 4616-20. [
DOI:10.18203/2320-6012.ijrms20195527]
8. Mohammadtaghi Kashi T, Hojjati MT, Ayatollahi AA. Blood Product Management: A Comprehensive Analysis in a Trauma Center Hospital. Arch Iran Med. 2025; 28(2):107-11. [
DOI:10.34172/aim.31324] [
PMID] [
PMCID]
9. Gharib C, Najaf B, Islami H, Asadinezhad SH. Monitoring the frequency of request and transfusion of blood products in Razi Hospital, the North of Iran. J Cur Biomed R. 2023; 4(4):111-15. [
DOI:10.61882/jcbior.4.4.243]
10. Jitmun P, Chatmongkolchart S. Efficacy of Blood Utilization in Elective Surgery for Non-COVID Patients during COVID-19 Outbreaks. J Health Sci Med Res 2025; 43(1): e20241058. [
DOI:10.31584/jhsmr.20241058]
11. Thakur SK, Sinha AK, Negi DK, Singh S. Effect of COVID-19 pandemic on blood transfusion service: an experience from a regional blood transfusion center. Blood Sci. 2023; 5(3): 209-17. [
DOI:10.1097/BS9.0000000000000161] [
PMID] [
PMCID]
12. Ali S, Botnarciuc M, Badea IA, Alexandru A, Tuta LA, Daba LC, et al. Impact of the COVID-19 Pandemic on Blood Transfusion among Hospitalized Patients with Chronic Kidney Disease. Medicina (Kaunas). 2024; 60(9):1512. [
DOI:10.3390/medicina60091512] [
PMID] [
PMCID]
13. Jeganathan-Udayakumar P, Tochtermann N, Beck T, Wertli MM, Baumgartner C. Haemoglobin thresholds for transfusion: how are we doing in the era of Choosing Wisely? A retrospective cohort study. Swiss Med Wkly. 2023;153:40132. [
DOI:10.57187/smw.2023.40132] [
PMID]
14. De Santo LS, Romano G, Mango E, Iorio F, Savarese L, Numis F, et al. Age and blood transfusion: relationship and prognostic implications in cardiac surgery. J Thorac Dis. 2017; 9(10):3719-27. [
DOI:10.21037/jtd.2017.08.126] [
PMID] [
PMCID]
15. Räsänen J, Ellam S, Hartikainen J, Juutilainen A, Halonen J. Sex Differences in Red Blood Cell Transfusions and 30-Day Mortality in Cardiac Surgery: A Single Center Observational Study. J Clin Med. 2023;12(24): 7674. [
DOI:10.3390/jcm12247674] [
PMID] [
PMCID]